TeleTrader 3/2/2021 WH: Biden admin sped up J&J, Merck deal
TeleTrader 3/2/2021 Merck to help J&J manufacture COVID vaccine - report
TeleTrader 2/25/2021 Merck to buy Pandion in $1.8 billion cash deal
TeleTrader 2/4/2021 Merck to appoint Robert Davis as new CEO
TeleTrader 2/4/2021 Merck sales rise 5% to $12.5B in Q4
GlobeNewswire 1/26/2021 Sanofi, Merck KGaA, Darmstadt, Germany, and More Than 500 Sites Join Inato in Making Clinical Resear...
GlobeNewswire 1/19/2021 Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under E...
TeleTrader 12/23/2020 Merck, US gov't sign COVID therapeutic supply deal
TeleTrader 12/2/2020 Merck divests direct holding in Moderna
TeleTrader 11/23/2020 Merck to buy COVID therapy candidate maker OncoImmune
GlobeNewswire 11/10/2020 An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
TeleTrader 10/27/2020 Merck revenue rises 1% YoY to $12.6B in Q3
GlobeNewswire 9/17/2020 Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTR...
pressetext 9/15/2020 PTA-News: 4SC AG: 4SC expands avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfiz...
GlobeNewswire 9/9/2020 NKMax America Announces a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmsta...
GlobeNewswire 8/6/2020 Cocrystal Pharma Reports Second Quarter 2020 Financial Results and Provides Updates on Antiviral Pro...
TeleTrader 7/31/2020 Merck EPS rise by 15% to $1.18 in Q2
GlobeNewswire 7/6/2020 Amid Global Pandemic, Launch of Smart Safety Syringe to Maximize Availability of Life-Saving Medici...
GlobeNewswire 6/24/2020 Yumanity Therapeutics Announces Strategic Research Collaboration and License Agreement with Merck Fo...
GlobeNewswire 6/9/2020 Vaccinex, Inc. to Present at the Virtual Investor Fireside Chat Series
TeleTrader 5/26/2020 COVID-19 vaccine time target 'very aggressive' - Merck CEO
TeleTrader 5/26/2020 Merck to work with IAVI on coronavirus vaccine
GlobeNewswire 5/20/2020 Surface Oncology and Merck to Collaborate on Immuno-Oncology Study Evaluating SRF617, Targeting CD39...
GlobeNewswire 5/13/2020 Vaccinex to Present Updated Results from CLASSICAL-Lung, Phase 1b/2 Study of Pepinemab (VX15/2503) i...
TeleTrader 4/28/2020 Merck & Co's EPS climbs 13% to $1.26 in Q1